Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation
1. In this systematic review and meta-analysis, catheter ablation was found to reduce overall risk of ischemic stroke, hospitalization for ...
Tag: congestive heart failure
Mineralocorticoid receptor antagonists reduce hospitalizations in patients with heart failure with preserved or mildly reduced ejection fraction
1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. ...
Bayer’s Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure
A phase 3 trial showed Kerendia reduced the risk of cardiovascular death by 16% compared to placebo. Hyperkalemia was greater ...
Semaglutide reduces heart failure events in patients with preserved ejection fraction
1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant ...
Semaglutide reduces cardiovascular events in patients with atherosclerotic disease and obesity
1. Patients assigned to semaglutide reported reduced major adverse cardiovascular events, regardless of heart failure subtype. 2. Benefits were consistent ...
Adaptive resynchronization shows no benefit over conventional biventricular resynchronization in patients with heart failure
1. All-cause mortality after 5 years was similar for patients in the adaptive and conventional CRT groups. 2. System-related adverse ...
Hemodynamic monitoring improves quality of life and reduces hospitalizations in heart failure patients
1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The ...
#VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
1. In this randomized clinical trial, among 2859 patients, death occurred in 26.1% of patients randomized to torsemide and 26.2% ...
Interatrial shunt device not effective in patients with symptomatic heart failure
1. There was no significant difference in the primary composite endpoint between the interatrial shunt and sham procedure groups. 2. ...
Predicted long-term effects of dapagliflozin in heart failure suggest association with improved event-free survival
1. A prediction of the long-term effects of dapagliflozin from the short-term data in the Dapagliflozin and Prevention of Adverse-Outcomes ...